Edwards MITRIS RESILIA Valve Receives CE Mark for Mitral Replacement Surgeries

Contributed by: Business Wire

Images

The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)
Business Wire embedded0

Tags

Health
Medical Devices
Managed Care
Research
Science
Pharmaceutical
Biotechnology
CE mark

More Like This

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability

Business Wire logo

ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology

PR Newswire associated0

/C O R R E C T I O N -- KingstronBio/

PR Newswire associated0

First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study

PR Newswire associated0

Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025

Business Wire logo

Edwards Launches SAPIEN 3 With Alterra Prestent in Europe for Transcatheter Pulmonic Valve Implantation

PR Newswire associated0

Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR LondonValves 2024

Carillon Mitral Contour System®

Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®